Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report

A randomized controlled study of rituximab demonstrated that the drug protects pancreatic function in patients with acute-onset type 1 diabetes mellitus (AOT1DM). However, the mechanism of this protective effect is poorly understood. We examined the effects of rituximab in two patients with AOT1DM i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Endocrinol Diabetes Metab Case Rep
Päätekijät: Kurozumi, Akira, Okada, Yosuke, Arao, Tadashi, Miyazaki, Yusuke, Yoshikawa, Maiko, Torimoto, Keiichi, Kubo, Satoshi, Nakayamada, Shingo, Tanaka, Yoshiya
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Bioscientifica Ltd 2016
Aiheet:
Insight into Disease Pathogenesis or Mechanism of Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870497/
https://ncbi.nlm.nih.gov/pubmed/27252867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-16-0020
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia